• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

Molecular mechanism of cell senescence

Research Project

Project/Area Number 11557121
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Obstetrics and gynecology
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

WAKE Norio  Medical Institute of Bioregulation, Kyushu Univ., Professor, 生体防御医学研究所, 教授 (50158606)

Co-Investigator(Kenkyū-buntansha) ARIMA Takahiro  Medical Institute of Bioregulation, Kyushu Univ., Research Associate, 生体防御医学研究所, 助手 (80253532)
KATO Kiyoko  Medical Institute of Bioregulation, Kyushu Univ., Assistant Professor, 生体防御医学研究所, 講師 (10253527)
KATO Hidenori  Medical Institute of Bioregulation, Kyushu Univ., Assistant Professor, 生体防御医学研究所, 講師 (60214392)
MATSUDA Takao  Medical Institute of Bioregulation, Kyushu Univ., Research Associate, 生体防御医学研究所, 助手 (10304825)
Project Period (FY) 1999 – 2001
KeywordsSenescence gene / 1q42 and 7q11 / [12Val] K-Ras / ER α / p14ARF / MDM2 / p53 / Cell senescence / HDAC / Molecular target therapy
Research Abstract

The present study investigated accelerated cell senescence mechanism and its application to molecular target therapy for cancers.
1. ER α activated its transcriptional activity in response to the activated [12Val] K-Ras (K12V cells) and contributed to the NIH3T3 cell transformation. Dominant-negative ER expression resulted in the induction of senescence of K12V cells. Downregulation of MDM2 corresponded to the upregulation of p21 CDK inhibitor through p53 stabilization was involved in this cell senescence induction. ER α cDNA expression in NIH3T3 cells upregulated MDM2 expression. Co-expression of dominant-negative ER and c-Jun restored the MDM2 expression in K12V cells. The data implicate K-Ras/ER α/MDM2/p53 signalling in the regulation of cell senescence.
2. Cell senescence inducting candidate genes have been from 1q42 and 7q11 regions, respectively. Now, we are investigating biological activities of these genes by transfecting endometrial cancer and choriocarcinoma cell lines.
3. Sodium Butyrate (NaB) that is a potent HDAC inhibitor elicited the G0/G1 arrest and subsequent cell senescence in several cancer cells with intact pRb protein through p53 independent p21 upregulation. In turn, NaB arrested cervical cancer with inactive pRb both G0/G1 and G2/M and induced cell senescence. Thus, cell senescence induction by NaB is pRb independent. NaB upregulated ECM and its receptors downstream of p21.

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Kato K et al.: "Relevance of ER to the development of endometrial hyperplasia and adenocarcinoma"Breast Cancer. 6,4. 312-319 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kato H et al.: "Suppressed tumorigenicity of human endometrial cancer cells by the restored expression of DCC gene"Br. J. Cancer. 82,2. 459-466 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ueoka Y et al.: "Hepatocyte growth factor modulates motility and invas iveness of ovarian carcinomas via Ras-mediated pathway"Br. J. Cancer. 84,4. 891-899 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Wang D et al.: "Analysis of specific gene mutations in the transforming growth factor-β signal transduction pathway in human ovarian cancer"Cancer Research. 60. 4507-4512 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Terao Y: "Sodium butyrate induces growth arrest and senescence-like Phenotypes in gynecological cancer cells"International Journal of cancer. 94. 257-267 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kato et al.: "Contribution of estrogen receptora (ERa) to oncogenic K-Ras-mediated NIH3T: cell transformation and its implication for escape from senescence by modulating the p53 pathway"Journal of Biological Chemistry. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 和氣徳夫 他: "新女性医学大系 44 婦人科悪性腫瘍の薬物・放射線療法"新しい治療法の試み II遺伝子治療-基礎と臨床. 7 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kato K et al: "Relevance of ER to the development of endometrial hyperplasia and adenocarcinoma"Breast Cancer. 6, 4. 312-319 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kato K et al: "Suppressed tumorigenicity of human endometrial cancer cells by the restored expression of DCC gene"Br. J. Cancer. 82, 2. 459-466 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ueoka Y et al: "Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway"Br. J. Cancer. 84, 4, 2. 891-899 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Wang D et al: "Analysis of specific gene mutations in the transforming growth factor-β signal transduction pathway in human ovarian cancer"Cancer Research. 60. 4507-4512 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Terao Y et al: "Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecological cancer cells"International Journal of cancer. 94. 257-267 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kato K et al: "Contribution of estrogen receptora (ERa) to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway"Journal of Biological Chemistry. (in press).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi